BNTGF:OTC-Brenntag AG (USD)

COMMON STOCK | Specialty Chemicals | OTC

Last Closing Price

USD 81.25

Change

0.00 (0.00)%

Market Cap

USD 12.68B

Average Target Price

N/A
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Brenntag AG purchases and supplies industrial and specialty chemicals, and ingredients in Europe, the Middle East, Africa, North America, Latin America, the Asia Pacific, and internationally. It provides value-added services, such as just-in-time delivery, product mixing, blending, repackaging, inventory management, and drum return handling, as well as technical and laboratory services for specialty chemicals. The company serves customers in various end-market industries, including adhesives, paints, oil and gas, food, water treatment, personal care, and pharmaceuticals. Brenntag AG was founded in 1874 and is based in Essen, Germany.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-01-25 )

Largest Industry Peers for Specialty Chemicals

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SXYAY Sika AG

+0.16 (+0.57%)

USD39.62B 62.03 33.69
SKFOF Sika AG

-0.50 (-0.18%)

USD39.62B 61.66 32.88
GVDBF Givaudan SA

N/A

USD37.56B 52.88 32.61
GVDNY Givaudan SA

+1.40 (+1.71%)

USD37.56B 53.31 32.61
RDSMY Koninklijke DSM N.V

+0.09 (+0.20%)

USD30.84B 27.48 27.55
KDSKF Koninklijke DSM N.V

N/A

USD30.84B 27.29 27.55
NPCPF Nippon Paint Holdings Co., Ltd

N/A

USD29.59B 95.63 0.29
EMSHF EMS-CHEMIE HOLDING AG

N/A

USD22.13B 42.35 40.77
AKZOY Akzo Nobel N.V

-0.65 (-1.86%)

USD19.95B 31.18 16.62
AKZOF Akzo Nobel N.V

-1.27 (-1.22%)

USD19.95B 25.41 16.62

ETFs Containing BNTGF

Symbol Name Weight Mer Price(Change) Market Cap
XDGM:LSE Xtrackers Germany Mittels.. 0.00 % 0.40 %

-0.29 (-1.02%)

USD0.09B
C007:XETRA Lyxor MDAX (DR) UCITS ETF 0.00 % 0.30 %

-0.26 (-0.90%)

USD0.22B
F751:XETRA ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXV7:XETRA iShares STOXX Europe 600 .. 0.00 % 0.46 %

-1.48 (-1.34%)

USD0.13B
EXS3:XETRA iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

-1.95 (-0.73%)

USD1.70B
ELF1:XETRA Deka MDAX UCITS ETF 0.00 % 0.00 %

-2.50 (-0.83%)

USD0.67B
E907:XETRA Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

-1.24 (-0.74%)

USD0.12B
C064:XETRA ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
XDGM:F Xtrackers Germany Mittels.. 0.00 % 0.40 %

-0.27 (-0.95%)

USD0.07B
C007:F ComStage MDAX UCITS ETF 0.00 % 0.30 %

-0.23 (-0.81%)

USD0.19B
F751:F ComStage Alpha Deutschlan.. 0.00 % 0.69 %

N/A

USD0.01B
EXV7:F iShares STOXX Europe 600 .. 0.00 % 0.46 %

-1.56 (-1.41%)

USD0.13B
EXS3:F iShares MDAX UCITS ETF (D.. 0.00 % 0.51 %

-2.10 (-0.79%)

USD1.50B
ELF1:F Deka MDAX UCITS ETF 0.00 % 0.00 %

-2.35 (-0.78%)

USD0.56B
E907:F Lyxor 1 MDAX UCITS ETF 0.00 % 0.30 %

-1.38 (-0.82%)

USD0.11B
C064:F ComStage - STOXX® Europe.. 0.00 % 0.25 %

N/A

USD0.01B
XDGM:XETRA Xtrackers Germany Mittels.. 0.00 % 0.40 %

-0.29 (-1.02%)

USD0.09B

Market Performance

  Market Performance vs.
Industry/Classification (Specialty Chemicals)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.17% 43% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.17% 44% F 41% F
Trailing 12 Months  
Capital Gain 58.01% 68% D+ 69% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 58.01% 68% D+ 68% D+
Trailing 5 Years  
Capital Gain 66.50% 59% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.50% 58% F 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 3.39% 49% F 48% F
Dividend Return 2.02% 66% D 47% F
Total Return 5.42% 47% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 19.08% 75% C 76% C
Risk Adjusted Return 28.39% 59% F 60% D-
Market Capitalization 12.68B 81% B- 91% A-
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Specialty Chemicals)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 27.30 36% F 27% F
Price/Book Ratio 2.97 44% F 36% F
Price / Cash Flow Ratio 14.42 30% F 13% F
EV/EBITDA 11.98 45% F 30% F
Management Effectiveness  
Return on Equity 13.29% 82% B- 83% B
Return on Invested Capital 10.08% 65% D 70% C-
Return on Assets 5.05% 75% C 85% B
Debt to Equity Ratio 54.24% 42% F 35% F
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 1.17 33% F 38% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Higly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.